ING GROEP NV – Edwards Lifesciences Corporation Transaction History
ING GROEP NV portfolio value:
$8.02M
portfolio value
ING GROEP NV quarter portfolio value change:
-13.10%
quarter
Edwards Lifesciences Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.95% | -19.83K shares | -3.09M | $82.63 | 97.16K |
| Q2 2022 | share | Increase | +18.12% | 17.94K shares | -535K | $95.09 | 117K |
| Q1 2022 | share | Decrease | -36.29% | -56.43K shares | -8.48M | $117.72 | 99.05K |
| Q4 2021 | share | Increase | +23.08% | 29.15K shares | 5.84M | $130.68 | 155.48K |
| Q3 2021 | share | Increase | +147.44% | 75.27K shares | 9.01M | $113.21 | 126.33K |
| Q2 2021 | share | Increase | +23.47% | 9.70K shares | 1.83M | $103.57 | 51.05K |
| Q1 2021 | share | Increase | +0.02% | 10 shares | -313K | $83.64 | 41.34K |
| Q4 2020 | share | Increase | +200.43% | 27.57K shares | 2.67M | $91.23 | 41.33K |
| Q3 2020 | share | Increase | +162.55% | 8.51K shares | 736K | $79.82 | 13.76K |
| Q2 2020 | share | Increase | 0.00% | 5.24K shares | 362K | $69.11 | 5.24K |
| Q1 2020 | share | Decrease | -100.00% | -42.91K shares | -3.33M | $62.87 | 0 |
| Q4 2019 | share | Increase | +10.22% | 3.97K shares | 483K | $77.76 | 42.91K |
| Q3 2019 | share | Decrease | -50.62% | -39.91K shares | -2.00M | $73.3 | 38.94K |
| Q2 2019 | share | Decrease | -1.35% | -1.08K shares | -242K | $61.58 | 78.85K |
| Q1 2019 | share | Increase | 0.00% | 79.93K shares | 5.09M | $63.78 | 79.93K |
| Q4 2018 | share | Decrease | -100.00% | -34.44K shares | -1.99M | $51.06 | 0 |
| Q3 2018 | share | Increase | +384.39% | 27.33K shares | 1.65M | $58.03 | 34.44K |
| Q2 2018 | share | Decrease | -88.96% | -57.26K shares | -2.64M | $48.52 | 7.11K |
| Q1 2018 | share | Increase | +90.85% | 30.64K shares | 1.72M | $46.51 | 64.37K |
| Q4 2017 | share | Decrease | -50.91% | -34.98K shares | -1.23M | $37.57 | 33.73K |
| Q3 2017 | share | Increase | +41.21% | 20.05K shares | 586K | $36.44 | 68.71K |
| Q2 2017 | share | Decrease | -0.70% | -345 shares | 381K | $39.41 | 48.66K |
| Q1 2017 | share | Decrease | -8.17% | -4.36K shares | -130K | $31.36 | 49.00K |
| Q4 2016 | share | Increase | +33.10% | 13.27K shares | 73K | $31.23 | 53.37K |
| Q3 2016 | share | Increase | +503.70% | 33.45K shares | 1.37M | $40.19 | 40.09K |
| Q2 2016 | share | Decrease | -54.85% | -8.07K shares | -212K | $33.24 | 6.64K |
| Q1 2016 | share | Decrease | -99.04% | -1.51M shares | -39.79M | $29.4 | 14.71K |